Genomics platform
The platform brings together technical activities in cytogenetics and molecular genetics, all centered around a single automated system or chain of automated systems (nucleic acid extractors, thermocyclers including real-time systems, PCR , sequencers, etc.) and/or a shared technological approach (molecular biology, genomics, cytogenetics, etc.). This integration allows for the pooling of human and technical resources. The genomics platform thus combines the technical activities of the genetics,pathology and cytology,hematology, cytomolecular oncogenetics federation, cancer molecular genetics platform, biochemistry ,pharmacology ,HLA, and all other sectors requiring these approaches.
The objective is to benefit from groups of specialized and experienced technicians in their analytical methods, to bring together/unify training and to optimize the time spent on positions in order to consider new developments and innovations in all areas of medical biology.
The Genomics Platform is organized into two sub-sectors: molecular genetics and cytogenetics.
-
Team
-
Acting as Health ExecutiveGenomics – BDR
-
Acting EngineerNucleic acid sequencing manager
-
Bioinformatician
-
Senior healthcare executive
The platform includes 1 Health Manager, 25 Technicians, 1 Laboratory Assistant and 2 Engineers.
The genomics platform works mainly in conjunction with the services of genetics,pathological anatomy and cytology,biological hematology, the federative structure of cyto-molecular oncogenetics, the molecular genetics platform for cancers, biochemistry, pharmacology and HLA .
-
-
Activities
CIP (Interdepartmental Steering Committee)- Platform coordinators: Guénaëlle Levallet, Nicolas Richard, François Gravey
- Platform health manager: Olivia Ferec, alternate: Manuela Leroux
- Platform engineer: Nadia Coudray
- Bioinformatics Engineer: Bryce Leterrier
- Laboratory Manager: Simon Le Hello
- Senior manager of the Biology-Hygiene department: Mélanie Nonennmacher
- Heads of departments (or their representative) of disciplines using the genomics platform.
- Biologists using the genomics platform
- Technical staff representatives: Brice Coulleray (Oncogenetics), Maryse Artu (Constitutional Genetics), Nathalie Millerioux (Cytogenetics)
- Representative of the Biomedical Department: Catalina Vialle
- Representative of the Information Systems Department: Irvin Madec
- Quality Assurance Manager: Pauline Olivier
Main missions of the CIP- Validate the coordinators proposed by the Laboratory Manager, elected for a renewable 4-year term
- Decide how the platform will operate
- Validate the choice of hardware and software as determined by the Equipment Committee of the Caen Normandy University Hospital
- Evaluate the feasibility and validate the development and production of the new analyses
Large equipment- Nucleic acid extractors (Maxwell RSC 48, Promega; Maxwell RSC, Promega; Quickgene)
- EP MOTION pipetting robot (5073 L, Eppendorf)
- Fleet of 16 conventional thermocyclers, 3 real-time (LightCycler 480, Roche; 7500 Fast, Applied Biosystems) and 3 Idylla drawers (Biocartis)
- Droplet Digital PCR (QX200 Droplet Digital PCR System and QX600 Droplet Digital PCR System, Biorad)
- Labchip (GX Touch HT, Perkinelmer)
- 2 Bookstore Preparation Systems (ZEPHYR NGS IQ, PerkinElmer; STAR NGS, Hamilton)
- Sanger sequencer (SeqStudio, Applied Biosystems)
- 3 High-Speed Sequencers (Nextseq550, Illumina; S5 Prime + Ion Chef Instrument, Thermo Fisher and two Miseq, Illumina, one of which is DX, Illumina)
- Scanners (CGH: SureScan G2600D, Agilent; FISH: DM5500 B/DM6 B/DMR, Leica; Pathscan, Excilone)
- Cell sorter (AutoMACS Pro Separator, Miltenyi Biotec)
- Numbering device (XN-L-450, sysmex)
-
Platform News
February 2025: The Genomic PTF routinely implements a new high-throughput sequencing panel!A new panel (named NGS_SP) developed in particular by the doctors/biologists of the Genetics (Head: Dr Nicolas Gruchy) and Biological Hematology (Head: Prof Yohann Repessé) departments, with the methodological help of the engineer of the Genomic PTF, Nadia Coudray, has been deployed since the beginning of 2025.
- A new panel for what purpose?: the simultaneous sequencing of 55 genes!
- A new panel for which pathologies?: solid tumors and certain malignant hematological disorders.
- Run frequency: 2 times per week.
July 2024: The Genomic PTF routinely implements a new high-throughput sequencing panel!A new panel (named NGS_LP) developed in particular by the doctors/biologists of the Genetics (Head: Dr Nicolas Gruchy) and Biological Hematology (Head: Prof Yohann Repessé) departments, with the methodological help of the engineer of the Genomic PTF, Nadia Coudray, has been deployed since the summer of 2024.
- A new panel for what purpose?: the simultaneous sequencing of 177 genes!
- A new panel for which pathologies?: malignant hematological diseases but not only… any fresh sample can be analyzed on this panel (ex: vascular pathologies).
- Run frequency: once every 15 days.